Darexaban (YM150), an oral direct factor Xa inhibitor, has no effect on the pharmacokinetics of digoxin Takeshi KadokuraDorien GroenendaalHartmut Onkels Original Paper 11 June 2013 Pages: 1 - 9
Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats Myung-Jin ChoiSileshi Belew YohannesSeung-Chun Park Original Paper 08 June 2013 Pages: 11 - 16
Effect of natural borneol on the pharmacokinetics and distribution of nimodipine in mice Chun WuQiongfeng LiaoZhiyong Xie Original Paper 15 May 2013 Pages: 17 - 24
Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study Kai Jie ChenWan Yi ChenLi Chen Original Paper 17 May 2013 Pages: 25 - 31
Integration of preclinical and clinical knowledge to predict intravenous PK in human: Bilastine case study Valvanera VozmedianoIgnacio OrtegaMaria Luisa Lucero Original Paper 26 April 2013 Pages: 33 - 41
The effect of mirabegron, a potent and selective β3-adrenoceptor agonist, on the pharmacokinetics of CYP2D6 substrates desipramine and metoprolol Walter KrauwinkelJames DickinsonMarcel van Gelderen Original Paper 01 June 2013 Pages: 43 - 52
Effect of chronic hypoxic hypoxia on oxidation and glucuronidation of carvedilol in rats Shizuka YamauraMiki FukaoYukiya Hashimoto Original Paper 06 June 2013 Pages: 53 - 59
Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles Xiaoyun ZhaoWei LiXiangrong Zhang Original Paper 23 May 2013 Pages: 61 - 67
A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design Daniel DuDarren TargettAlessandra Canali Original Paper 17 May 2013 Pages: 69 - 75
